Trial intelligence / Profile preview

Prednisolone in patients undergoing total hip arthroplasty

IRCT20200118046174N3Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Sep 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of prednisolone in hip fracture, sponsored by Tehran University of Medical Sciences. Started Sep 2020; status: completed.

02

Drugs

prednisolone
03

Conditions

hip fracture

Beyond the preview

Go deeper on IRCT20200118046174N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200118046174N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call